EP4385509
Mígalastat-skömmtun sem hefur bætta lyfjahvarfafræði
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
31.5.2023EP published:
3.9.2025EP application number:
23176366.5
EP translation filed:
26.11.2025Grant published:
15.12.2025EPO information:
European Patent Register
Max expiry date:
30.5.2043Expiry date:
30.5.2026
Title in English:
MIGALASTAT DOSAGE REGIMEN HAVING IMPROVED PHARMACOKINETICSLanguage of the patent:
English
Timeline
Today
31.5.2023EP application
3.9.2025EP Publication
26.11.2025Translation submitted
15.12.2025Registration published
30.5.2026Expires
Owner
Name:
Amicus Therapeutics, Inc.Address:
3675 Market Street, Philadelphia, PA 19104, US
Inventor
Name:
JOHNSON, FranklinAddress:
Philadelphia, PA 19104, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
202263432235 PDate:
13.12.2022Country:
US
Number:
202318315928Date:
11.5.2023Country:
US
Classification
Categories:
A61K 31/445, A61K 31/522, A61P 3/00